Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
VALEANT PHARMA I RG (NY: VRX)
17.47 USD  -0.07 (-0.40%)
Official Closing Price  /  Updated: 8:04 PM EDT, Apr 24, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 6,478,384
Open 17.55
Bid (Size) 17.42 (600)
Ask (Size) 17.54 (2000)
Prev. Close 17.54
Today's Range 17.22 - 17.93
52wk Range 8.311 - 24.43
Shares Outstanding 348,708,567
Dividend Yield N/A
Performance
YTD
-19.83%
-19.83%
1 Month
+10.99%
+10.99%
3 Month
-21.66%
-21.66%
6 Month
+44.14%
+44.14%
1 Year
+103.14%
+103.14%
Top News
More News
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") today announced that Valeant Pharmaceuticals International, a wholly owned indirect subsidiary of Valeant, will redeem $150... Read More
from PR Newswire
Biotech Drug Production Pipeline Increasing Amid Buzz of Market Optimism
from PR Newswire
More News
Read More
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program
from PR Newswire
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration
from PR Newswire
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery
from PR Newswire
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes
from PR Newswire
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology
from PR Newswire
Stocks Generating Improved Relative Strength: Valeant Pharmaceuticals
from Investor's Business Daily
New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP — Consolida
from GlobeNewswire News Releases
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
from GlobeNewswire News Releases
BRIEF-U.S. International Trade Commission Says Will Probe Certain Clidinium Bromide-Containing Products After Valeant Pharmaceuticals Filed Complaint -Statement
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial